Industry Experts

Dr. Paul (Weibing) Shi has over 15 years of experience in computational biology, bioinformatics, and biomarker analysis. As Scientific Associate Director at Amgen, he leads a team generating critical biomarker data and overseeing infrastructure projects and Omics platform development. His team leverages AI/ML technologies for biomarker data processing and predictive signature development, enhancing drug discovery and development. At Roche and other renowned institutions, Dr. Shi developed bioinformatics workflows and managed large-scale NGS projects. Passionate about inclusivity, he champions the EPR (Encourage, Praise, and Recognize) approach to empower teams. Dr. Shi has authored over 20 scientific publications and is a certified SAFe® 5 Agilist.